RPG Life Sciences
RPGLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Harsh Goenka · MD: Yugal Sikri · Listing date: June 11, 2008 · Employees: 1107 · Mumbai · http://www.rpglifesciences.com

Stock Price vs Company Growth
1d
1.9%
1w
2.3%
1m
8.9%
3m
0.8%
6m
43.9%
1y
62.3%
5y
49.0%
10y
40.0%
all
28.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,224 1.9%
1,955
2,977
Company Overview

Sales
618 Cr
Growth: 11.7%
Profit after Tax
70.7 Cr
Growth: -23.5%
Small Cap
3,679 Cr
P/E: 52.1x
Industry P/E: 37.3x
Fundamentals

Sales (Cr) ₹ 618
Growth 11.7%
EBITDA 23.2%
P/S 5.9x
Dividend 1.2%
P/E 52.1x
Book Value ₹ 245
PEG Ratio 4.5x
ROE 18.1%
P/B 9.1x
Shareholding Pattern

Institutions
Promoters
Nucleus Life Trust (Mr. Harsh Vardhan Goenka Is A Trustee)
53.42 %
Ektara Enterprises Llp
15.2 %
Stel Holdings Limited
3.18 %
Harsh Vardhan Goenka
0.16 %
Mala Goenka
0.05 %
Others
Authum Investment And Infrastructure Limited
1.98 %
Iepf
0.86 %
Llp
0.02 %
Increase    Decrease    No change
Company Profile Detailed

RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company’s name was changed to RPG Life Sciences Ltd effective April 1, 1999.
Investors (59)
Followers (4)